about
Epicardial Ablation of Ventricular TachycardiaNeuraxial modulation for treatment of VT stormOur approach to minimize risk of epicardial access: standard techniques with the addition of electroanatomic mapping guidance.Characterization of the arrhythmogenic substrate in ischemic and nonischemic cardiomyopathy implications for catheter ablation of hemodynamically unstable ventricular tachycardia.Improved late gadolinium enhancement MR imaging for patients with implanted cardiac devicesCardiac involvement in sarcoidosis: evolving concepts in diagnosis and treatmentRadiofrequency ablation of drug refractory ventricular tachycardia related to cocaine use: a feasibility, safety, and efficacy studyCatheter ablation of scar-based ventricular tachycardia: Relationship of procedure duration to outcomes and hospital mortalityBiophysical parameters during radiofrequency catheter ablation of scar-mediated ventricular tachycardia: epicardial and endocardial applications via manual and magnetic navigation.Percutaneous left ventricular assist devices in ventricular tachycardia ablation: multicenter experience.Freedom from recurrent ventricular tachycardia after catheter ablation is associated with improved survival in patients with structural heart disease: An International VT Ablation Center Collaborative Group study.Quantitative analysis of localized sources identified by focal impulse and rotor modulation mapping in atrial fibrillationBilateral cardiac sympathetic denervation for the management of electrical storm.Relationship between sinus rhythm late activation zones and critical sites for scar-related ventricular tachycardia: systematic analysis of isochronal late activation mappingNarrative review: drug-eluting stents for the management of restenosis: a critical appraisal of the evidence.Long-term clinical outcomes of focal impulse and rotor modulation for treatment of atrial fibrillation: A multicenter experienceA critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death.Electrical homogenization of ventricular scar by application of collagenase: a novel strategy for arrhythmia therapy.Device artifact reduction for magnetic resonance imaging of patients with implantable cardioverter-defibrillators and ventricular tachycardia: late gadolinium enhancement correlation with electroanatomic mapping.Impact of local ablation on interconnected channels within ventricular scar: mechanistic implications for substrate modification.Managing patients with ICD shocks and programming tachycardia therapies during acute heart failure syndromes.Catheter ablation of ventricular tachycardia.Advances in ablation of ventricular tachycardia in nonischemic cardiomyopathy.Ventricular tachycardia in ischemic heart disease substratesMAGNETIC VT study: a prospective, multicenter, post-market randomized controlled trial comparing VT ablation outcomes using remote magnetic navigation-guided substrate mapping and ablation versus manual approach in a low LVEF population.A case of a human ventricular fibrillation rotor localized to ablation sites for scar-mediated monomorphic ventricular tachycardia.Permanent His-bundle pacing for cardiac resynchronization therapy: Initial feasibility study in lieu of left ventricular lead.Outcomes after repeat ablation of ventricular tachycardia in structural heart disease: An analysis from the International VT Ablation Center Collaborative Group.Sustained Ventricular Tachycardia in Apparently Normal Hearts: Ablation Should Be the First Step in Management.Selective versus non-selective his bundle pacing for cardiac resynchronization therapy."Left ventricular" AV nodal reentrant tachycardia: Case report and review of the literature.Usefulness of His Bundle Pacing to Achieve Electrical Resynchronization in Patients With Complete Left Bundle Branch Block and the Relation Between Native QRS Axis, Duration, and Normalization.Mortality prediction using a modified Seattle Heart Failure Model may improve patient selection for ventricular tachycardia ablation.Early Mortality After Catheter Ablation of Ventricular Tachycardia in Patients With Structural Heart Disease.Ventricular Tachycardia Ablation in Severe Heart Failure: An International Ventricular Tachycardia Ablation Center Collaboration Analysis.Left ventricular pseudoaneurysm as a complication of left ventricular summit premature ventricular contraction ablation.Atrial Arrhythmias and Electroanatomical Remodeling in Patients With Left Ventricular Assist Devices.Renal Denervation: A Novel Therapy at the Crossroads of Imaging, Intervention, and Innovation.Hyper-response to cardiac resynchronization with permanent His bundle pacing: Is parahisian pacing sufficient?Brugada syndrome-Malignant phenotype associated with acute cardiac inflammation?
P50
Q26797429-2FC79E59-2522-4B14-B636-800C3E7326F9Q28085693-046E3A52-E0F9-48D5-A33A-548E732648AEQ30541006-8C446561-70AB-431A-B7C0-4FF32790E5C4Q33960236-932CC72B-B08F-40B9-8114-380BBA7D490EQ34495297-879DF542-06FD-4969-97E3-9A685022A93FQ34617313-2398A640-7017-4FF5-953C-36AFFEA95B28Q34617342-299FD162-BB7D-4B36-A855-3E30A0D0BAFAQ34803916-259776DB-C688-4617-B0C8-C735CBF9196AQ34803941-0E11964F-CC75-45C6-95F5-3C1E143B6D33Q35086260-BA78E81C-3722-4870-A46B-D6DADBE9D20FQ35995550-329A3EDB-6BC8-4597-86E3-3EDC38D01F93Q36305081-9E42B29D-D40D-44C5-B060-7576D1A429A4Q36315676-77D426A6-C7F5-4BE4-A0C3-BD967D6BDB18Q36414543-CBE2F56F-FCC2-49A9-811D-00D75716A0B5Q36511835-EB377E65-B1E7-4CB7-8E71-E66A784D11E2Q36604704-4C2036A6-28EF-4412-9B7C-9B31EF3D8B17Q37274482-242C9E30-A05B-471B-88A8-A68B762F1D28Q37413056-18E83855-AE7E-48A0-8364-D537E84B9AC2Q37625286-7C9EF12D-AE42-4DC7-A6BE-46DCF373EFDBQ37687397-530B74D3-7A42-4EC6-8140-87D3614A93E0Q37859647-672945DA-3801-4F79-9D92-60119840F2CEQ37878767-1C128F63-0276-43FF-8389-2BF5CE34166FQ38030479-0D250FE2-D5E6-4FCA-BF8B-CC8A84C4BEF5Q38191067-A847EBC4-39E1-49BC-A666-8DAA4953BB81Q38382682-D99EF953-FD0C-465A-BC66-9CC45B6929D5Q38600473-8F2D368C-C4DB-4CFA-9DD7-26080D54067FQ38731692-A80A9977-A0F1-4050-9504-4949DDA3764FQ38785002-99AD47F6-04F7-40C0-95FB-1B3B44F1E540Q38926718-41C89553-1A4A-4DF3-B3A1-E41741C5E287Q39021403-4044997E-7CFD-4A81-A3A6-33D23A9764FCQ39297258-EB8CFF97-1452-4E71-8667-ACDCA7F6AC0BQ39655108-4D1DDC51-D856-4544-8CBF-2C9F96C77E11Q40200635-6D30F27D-3DBD-4ECA-92B8-C9B9CF3A99BAQ40224824-5B74556D-1555-45DF-896E-FBB0670D847BQ40382898-509E02B7-FD6D-4E53-AF94-A8948136754CQ41011312-04E32C7C-7476-4351-901B-69B391AE9A99Q41104074-D98C4735-16C6-48D8-BD34-691592F9DEF0Q41347475-055EDC5D-4E2E-4387-9A14-6BA35BA0999CQ41351208-7C91BE21-1D9A-4A9A-BC11-487D1C779BDFQ41427217-37EAFA87-8C29-4769-9528-05DFA7621E49
P50
description
cardiology researcher
@en
wetenschapper
@nl
name
Roderick Tung
@en
Tung R
@nl
type
label
Roderick Tung
@en
Tung R
@nl
altLabel
Tung R
@en
prefLabel
Roderick Tung
@en
Tung R
@nl
P106
P31
P496
0000-0002-8513-1303